Patient Power Investigators are studying the cancer risks related to high and low Immunoglobulin A (IgA) levels. Andrew Kin, M.D. , hematologist and medical oncologist, and member of the Bone Marrow & Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, discussed what certain levels of IgA may indicate, including conditions other than cancer. Read the article here .
CancerNetwork Karmanos Cancer Institute experts in multiple myeloma and chronic myeloid leukemia (CML) took part in a face-off against Cleveland Clinic. Andrew Kin, M.D. , hematologist and medical oncologist, and member of the Bone Marrow and Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams (MDTs), was the team captain for Karmanos. He was joined by Craig Cole, M.D. , hematologist, member of the Hematology Oncology and Multiple Myeloma and Amyloidos...
Patient Power Abhinav Deol, M.D. , and Andrew Kin, M.D. , both hematologists and medical oncologists and members of the Bone Marrow and Stem Cell Transplant , Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, explain the possible treatment options for multiple myeloma patients whose disease may have relapsed. Read the article here . Abhinav Deol, M.D. Andrew Kin, M.D.